| 2017 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients | Yeh, CN; Chang, YC; Su, Y; Hsu, DS; Cheng, CT; Wu, RC; Chung, YH; Chiang, KC; Yeh, TS; Lu, ML; Liu, CY; Chang, PM; Chen, MH; Huang, CY; Hsiao, M ; Chen, MH | Oncotarget 8(69), 113444-113459 | | | |
| 2019 | Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinom | Yeh, CN; Chen, MH; Chang, YC; Wu, RC; Tsao, LC; Wang, SY; Cheng, CT; Chiang, KC; Chen, TW; Hsiao, M ; Weng, WH | Molecular Carcinogenesis 58(2), 270-278 | | | |
